CN Mobile Logo

Search form


NCI Considers Lung Cancer Trial

NCI Considers Lung Cancer Trial

A subcommittee of the NCI’s Board of Scientific Advisors is considering whether to recommend that the NCI undertake a major, randomized clinical trial to look at the incidence of mortality among lung cancer patients who undergo a computed tomography (CT) scan. 

Daniel Sullivan, associate director of the biomedical imaging program at the NCI, said the trial could enroll as many as 20,000 patients at approximately 10 to 20 medical centers. The idea would be to determine whether tumors discovered as a result of a "screening CT" were detected early enough to positively affect the patient’s quality of life. 

Currently, health insurance rarely pays for a lung CT of an asymptomatic patient.

By clicking Accept, you agree to become a member of the UBM Medica Community.